Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Neuroprostanes [FA0401]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA04010503 14-J4-NeuroP (Z)-6-((1S,5S)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010504 ent-7,14-diepi-14-J4-NeuroP (Z)-6-((1S,5R)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010505 7-epi-14-J4-NeuroP (Z)-6-((1R,5S)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010506 ent-14-epi-14-J4-NeuroP (Z)-6-((1R,5R)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010507 17-epi-17-J4-NeuroP (4Z,7Z)-9-((1S,5S)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010508 ent-10-epi-17-J4-NeuroP (4Z,7Z)-9-((1S,5R)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010509 10,17-diepi-17-J4-NeuroP (4Z,7Z)-9-((1R,5S)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010510 ent-17-J4-NeuroP (4Z,7Z)-9-((1R,5R)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010511 17-J4-NeuroP (4Z,7Z)-9-((1S,5S)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010512 ent-10,17-diepi-17-J4-NeuroP (4Z,7Z)-9-((1S,5R)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010513 10-epi-17-J4-NeuroP (4Z,7Z)-9-((1R,5S)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010514 ent-17-epi-17-J4-NeuroP (4Z,7Z)-9-((1R,5R)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010515 20-epi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1S,5S)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010516 ent-13-epi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1S,5R)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010517 13,20-diepi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1R,5S)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010518 ent-20-J4-NeuroP (4Z,7Z,10Z)-12-((1R,5R)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010519 20-J4-NeuroP (4Z,7Z,10Z)-12-((1S,5S)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010520 ent-13,20-diepi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1S,5R)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010521 13-epi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1R,5S)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010522 ent-20-epi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1R,5R)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410